SPL Set ID: 67f821fa-5663-4d69-82c9-5ee13a09f324

Oxazepam, USP is the first of a chemical series of compounds known as the 3-hydroxybenzodiazepinones. A therapeutic agent providing versatility and flexibility in control of common emotional disturbances, this product exerts prompt action in a wide variety of disorders associated with anxiety, tension, agitation, and irritability, and anxiety associated with depression. In tolerance and toxicity studies on several animal species, this product reveals significantly greater safety factors than related compounds (chlordiazepoxide and diazepam) and manifests a wide separation of effective doses and doses inducing side effects. Oxazepam capsule, USP contains 10 mg, 15 mg, or 30 mg oxazepam, USP. The following inactive ingredients are contained in these capsules: lactose monohydrate, pregelatinized starch, croscarmellose sodium, hypromellose, sodium lauryl sulfate, and magnesium stearate. The capsule shell contains gelatin and titanium dioxide. The 10 mg capsule also contains: D&C Red #28 and FD&C Red #40, the 15 mg capsule also contains: FD&C Red #40 and D&C Yellow #10 and the 30 mg capsule also contains: D&C Red #28, FD&C Red #40 and FD&C Blue #1. The imprinting ink contains strong ammonia solution, black iron oxide, potassium hydroxide, propylene glycol, purified water, titanium dioxide, FD&C Blue #2 aluminum lake and shellac. Oxazepam, USP is 7-chloro-1,3-dihydro-3-hydroxy-5-phenyl-2H-1,4-benzodiazepin-2-one. A white crystalline powder with a molecular weight of 286.7, its structural formula is as follows: chemstucture.jpg